Melodi Health

Focus: Melodi Health is a newly-founded (2024) biotechnology company developing an absorbable antibacterial matrix for breast reconstruction applications. The company operates as a pre-revenue biotech focused on infectious disease prevention in surgical settings.

Infectious Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Melodi Health

AI assessmentNot Hiring

No open roles listed right now. Follow Melodi Health to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Absorbable Antibacterial Matrix

Breast Reconstruction

N/A

Clinical Trials (1)

NCT06027996Melodi Matrix™ in Breast Reconstruction

N/A

Help build intelligence for Melodi Health

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Ground-floor opportunity at a newly-launched company (founded 2024) with a focused, differentiated technology in an unmet clinical need
Specialized focus on breast reconstruction and infection prevention addresses a tangible surgical complication with commercial potential
Early-stage biotech environment enables direct impact on product development and strategy with minimal bureaucracy

Watch Out For

Zero active job openings reported suggests minimal hiring activity and potential scaling challenges post-launch
Lack of disclosed funding, financials, and clinical trial data (only 1 trial on record, phase not specified) creates significant uncertainty around runway and clinical progress
Founded in 2024 with no published data, patent information, or news coverage makes it impossible to validate scientific merit or management credibility

Generated by Claude from Melodi Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2024

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo